Polymerase inhibitor and method of using same

Details for Australian Patent Application No. 2004227353 (hide)

Owner Eragen Biosciences,Inc.

Inventors Larsen, Christine A.; Moser, Michael J.; Prudent, James R.; Van Hout, Cristopher V.; Marshall, David J.

Agent Griffith Hack

Pub. Number AU-B-2004227353

PCT Pub. Number WO2004/090153

Priority 60/459,672 01.04.03 US

Filing date 1 April 2004

Wipo publication date 21 October 2004

Acceptance publication date 25 February 2010

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12Q 1/48 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving transferase

Event Publications

27 October 2005 PCT application entered the National Phase

  PCT publication WO2004/090153 Priority application(s): WO2004/090153

25 February 2010 Application Accepted

  Published as AU-B-2004227353

24 June 2010 Standard Patent Sealed

17 May 2012 Alteration of Name

  The name of the patentee has been altered to Luminex Corporation

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004227358-Compounds and methods to enhance rAAV transduction

2004227352-Adhered membranes retaining porosity and biological activity in assay device for measuring serum cholesterol associated with high-density lipoproteins